Symbol="THRX"
AssetType="Common Stock"
Name="Theseus Pharmaceuticals Inc"
Description="Theseus Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. The company is headquartered in Cambridge, Massachusetts."
CIK="1745020"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="314 MAIN STREET, SUITE 04-200, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="144238000"
EBITDA="-60493000"
PERatio="None"
PEGRatio="None"
BookValue="5.66"
DividendPerShare="0"
DividendYield="0"
EPS="-1.29"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.15"
ReturnOnEquityTTM="-0.226"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.29"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="6.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.04"
EVToRevenue="-"
EVToEBITDA="-0.229"
Beta="None"
num_52WeekHigh="14.77"
num_52WeekLow="2.62"
num_50DayMovingAverage="7.21"
num_200DayMovingAverage="8.27"
SharesOutstanding="43576500"
DividendDate="None"
ExDividendDate="None"
symbol="THRX"
open="3.29"
high="3.34"
low="3.24"
price="3.31"
volume="257835.00"
latest_trading_day="2023-08-07"
previous_close="3.32"
change="-0.01"
change_percent="-0.3012%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="73"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="27"
Volume_recent_avg="470606"
Change_recent_avg="0.02"
Delta_recent_avg="0.67"
Variance_recent_avg="0.34"
Change_ratio_recent_avg="0.1"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="27"
Aroon_momentum_negative="73"
image_negative_thumbnail_id_1="1121"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0154.jpeg"
image_negative_thumbnail_id_2="1161"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0195.jpeg"
image_neutral_thumbnail_id_1="544"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_neutral_thumbnail_id_2="521"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_positive_thumbnail_id_1="663"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0045.jpeg"
image_positive_thumbnail_id_2="665"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0043.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
